ViroGates A/S

Symbol: VIRO.CO

CPH

6.84

DKK

Market price today

  • -3.4575

    P/E Ratio

  • 0.0783

    PEG Ratio

  • 44.08M

    MRK Cap

  • 0.00%

    DIV Yield

ViroGates A/S (VIRO-CO) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.79%

Operating Profit Margin

-2.09%

Net Profit Margin

-2.05%

Return on Assets

-0.63%

Return on Equity

-1.08%

Return on Capital Employed

-0.69%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Devices
CEO:Mr. Jakob Knudsen
Full-time employees:10
City:Birkerød
Address:BanevAenget 13
IPO:2018-06-26
CIK:

ViroGates A/S develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a blood test that measures the soluble urokinase plasminogen activator receptor (suPAR) protein in the bloodstream used for emergency departments in hospitals to improve clinical decisions on hospitalization or discharge of acute medical patients and reduce healthcare cost. The company also provides suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the suPAR level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic Quick Triage kit, which is used in the point of care situation for early warning and patient triaging; and suPARnostic ELISA that provides fully quantitative results. Its suPAR prognostic tool used in various diseases, such as cardiovascular, kidney, cancer, diabetes, liver, infectious, respiratory, and rheumatic. The company was incorporated in 2000 and is headquartered in Birkerød, Denmark.

General Outlook

When we look at how much money they make before expenses, they keep 0.789% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -2.089%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -2.049%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.632% return, is a testament to ViroGates A/S's adeptness in optimizing resource deployment. ViroGates A/S's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -1.081%. Furthermore, the proficiency of ViroGates A/S in capital utilization is underscored by a remarkable -0.695% return on capital employed.

Stock Prices

ViroGates A/S's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $6.6, while its low point bottomed out at $6.24. This variance in figures offers investors a lucid insight into the roller-coaster ride that is ViroGates A/S's stock market.

Liquidity Ratios

Analyzing VIRO.CO liquidity ratios reveals its financial health of the firm. The current ratio of 1364.26% gauges short-term asset coverage for liabilities. The quick ratio (1045.29%) assesses immediate liquidity, while the cash ratio (834.17%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio1364.26%
Quick Ratio1045.29%
Cash Ratio834.17%

Profitability Ratios

VIRO.CO profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -219.78% underscores its earnings before tax deductions. The effective tax rate stands at 6.78%, revealing its tax efficiency. The net income per EBT, 93.22%, and the EBT per EBIT, 105.23%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -208.85%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-219.78%
Effective Tax Rate6.78%
Net Income per EBT93.22%
EBT per EBIT105.23%
EBIT per Revenue-208.85%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 13.64, it details the span from stock purchase to revenue. The 10 days it takes to settle debts showcases its creditor relations. Meanwhile, a 8 cash conversion cycle and 201.07% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding1045
Days of Inventory Outstanding1301
Operating Cycle1482.68
Days of Payables Outstanding243
Cash Conversion Cycle1240
Receivables Turnover2.01
Payables Turnover1.50
Inventory Turnover0.28
Asset Turnover0.31

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -1.95, and free cash flow per share, -1.95, depict cash generation on a per-share basis. The cash per share value, 1.90, showcases liquidity position. Lastly, the operating cash flow sales ratio, -2.02, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-1.95
Free Cash Flow per Share-1.95
Cash per Share1.90
Operating Cash Flow Sales Ratio-2.02
Free Cash Flow to Operating Cash Flow Ratio1.00
Cash Flow Coverage Ratio-2.37

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 26.27%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.40, we discern the balance between debt and equity financing. The long-term debt to capitalization, 28.33%, and total debt to capitalization, 28.33%, ratios shed light on its capital structure. An interest coverage of -18.15 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio26.27%
Debt Equity Ratio0.40
Long Term Debt to Capitalization28.33%
Total Debt to Capitalization28.33%
Interest Coverage-18.15
Cash Flow to Debt Ratio-2.37
Company Equity Multiplier1.50

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 1.61, provides a glimpse into top-line earnings distributed across each share. Net income per share, -3.49, reflects the portion of profit attributed to each share. The book value per share, 4.91, represents the net asset value distributed per share, while the tangible book value per share, 4.91, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share1.61
Net Income Per Share-3.49
Book Value Per Share4.91
Tangible Book Value Per Share4.91
Shareholders Equity Per Share4.91
Interest Debt Per Share1.70

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -63.27%, indicates top-line expansion, while the gross profit growth, -65.55%, reveals profitability trends. EBIT growth, -15.86%, and operating income growth, -15.86%, offer insights into operational profitability progression. The net income growth, -25.40%, showcases bottom-line expansion, and the EPS growth, -52.40%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-63.27%
Gross Profit Growth-65.55%
EBIT Growth-15.86%
Operating Income Growth-15.86%
Net Income Growth-25.40%
EPS Growth-52.40%
EPS Diluted Growth-52.40%
Weighted Average Shares Growth-18.01%
Weighted Average Shares Diluted Growth-18.01%
Operating Cash Flow Growth14.69%
Free Cash Flow Growth14.69%
10-Year Revenue Growth per Share25.56%
5-Year Revenue Growth per Share44.11%
3-Year Revenue Growth per Share20.40%
10-Year Operating CF Growth per Share-51.23%
5-Year Operating CF Growth per Share36.35%
3-Year Operating CF Growth per Share9.85%
10-Year Net Income Growth per Share-85.62%
5-Year Net Income Growth per Share39.03%
3-Year Net Income Growth per Share25.44%
10-Year Shareholders Equity Growth per Share56.93%
5-Year Shareholders Equity Growth per Share-76.14%
3-Year Shareholders Equity Growth per Share-37.28%
Receivables Growth-12.26%
Inventory Growth36.31%
Asset Growth40.00%
Book Value per Share Growth28.94%
R&D Expense Growth-39.10%
SGA Expenses Growth-8.01%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 11,354,180, captures the company's total value, considering both debt and equity. Income quality, 1.01, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.61, gauges operational efficiency, while the research and development to revenue, 115.42%, highlights investment in innovation.

cards.indicatorcards.value
Enterprise Value11,354,180
Income Quality1.01
Sales General and Administrative to Revenue0.61
Research and Development to Revenue115.42%
Graham Number19.66
Return on Tangible Assets-49.26%
Graham Net Net3.89
Working Capital22,131,000
Tangible Asset Value17,007,000
Net Current Asset Value16,831,000
Average Receivables3,437,500
Average Payables1,066,500
Average Inventory4,454,500
Days Sales Outstanding210
Days Payables Outstanding466
Days of Inventory On Hand1535
ROIC-52.05%
ROE-0.71%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 3.29, and the price to book ratio, 3.29, reflect the market's valuation relative to the company's book value. The price to sales ratio, 7.08, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -3.51, and price to operating cash flows, -3.51, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio3.29
Price to Book Ratio3.29
Price to Sales Ratio7.08
Price Cash Flow Ratio-3.51
Price Earnings to Growth Ratio0.08
Enterprise Value Multiple-3.94
Price Fair Value3.29
Price to Operating Cash Flow Ratio-3.51
Price to Free Cash Flows Ratio-3.51
Price to Tangible Book Ratio1.30
Enterprise Value to Sales2.03
Enterprise Value Over EBITDA-0.91
EV to Operating Cash Flow-0.93
Earnings Yield-54.78%
Free Cash Flow Yield-55.16%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of ViroGates A/S (VIRO.CO) on the CPH in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -3.458 in 2024.

What is the ticker symbol of ViroGates A/S stock?

The ticker symbol of ViroGates A/S stock is VIRO.CO.

What is company IPO date?

IPO date of ViroGates A/S is 2018-06-26.

What is company current share price?

Current share price is 6.840 DKK.

What is stock market cap today?

The market cap of stock today is 44078307.000.

What is PEG ratio in 2024?

The current 0.078 is 0.078 in 2024.

What is the number of employees in 2024?

In 2024 the company has 10.